Galluppi Stefan's Form 4 filing
LifeMD, Inc. (LFMD) · filed Nov 18, 2021
- Accession no.
- 0001362118-21-000043
- Filed
- Nov 18, 2021
- Trade date
- Nov 17, 2021
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 3 non-derivative transactions. Open-market purchases total $8.87K. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Galluppi StefanCIK 0001722649 | Director, Officer (Chief Technology Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 17, 2021 | Common Stock, par value $0.01 | PPurchaseAcquired | +100 | $4.79 | +$479 | 6,093 | Direct | |
| Nov 17, 2021 | Common Stock, par value $0.01 | PPurchaseAcquired | +1,206 | $4.80 | +$5,788.8 | 7,299 | Direct | |
| Nov 17, 2021 | Common Stock, par value $0.01 | PPurchaseAcquired | +542 | $4.81 | +$2,607.02 | 7,841 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.